FDA Approves EPANOVA for the Treatment of Adults with Severe Hypertriglyceridemia

[PR Newswire] – WILMINGTON, Del., May 6, 2014 /PRNewswire/ — AstraZeneca (NYSE: AZN) today announced the US Food and Drug Administration (FDA) approved EPANOVA ® (omega-3-carboxylic acids) as an adjunct to diet to reduce … more

View todays social media effects on AZN

View the latest stocks trending across Twitter. Click to view dashboard

See who Astrazeneca is hiring next, click here to view